If you think about it, it's realistic that we could shut down ALK and reduce ALK function to see if we did stay skinny, aLK inhibitors are used in cancer treatments already. It's targetable. We could possibly inhibit ALK, and we actually will try to do this in the future.

Josef Penninger

Josef Penninger (born 5 September 1964) is an Austrian biomedical researcher specialising in molecular immunology. He is the scientific director of the Institute of Molecular Biotechnology located at the Vienna Biocenter. In February 2018, he announced his decision to leave Vienna and become the head of the Life Sciences Institute of the University of British Columbia in Vancouver, British Columbia, Canada.The asteroid 48801 Penninger is named in his honour.

All Josef Penninger quotes | Josef Penninger Books